ENGN · Categories · Form 3

ENGN - SEC Form 3 initial insider statements

enGene Therapeutics Inc. (ENGN) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for ENGN

• 257d
  SEC Form 3 filed by new insider Sweiti Hussein

  3 - enGene Holdings Inc. (0001980845) (Issuer)
• 336d
  New insider Boyd Matthew Ross claimed ownership of 7,500 shares (SEC Form 3)

  3 - enGene Holdings Inc. (0001980845) (Issuer)
• 342d
  SEC Form 3 filed by new insider Heffernan Michael Thomas

  3 - enGene Holdings Inc. (0001980845) (Issuer)
• 342d
  New insider Astley-Sparke Philip claimed ownership of 20,000 shares (SEC Form 3)

  3 - enGene Holdings Inc. (0001980845) (Issuer)
• 342d
  SEC Form 3 filed by new insider Grossman William

  3 - enGene Holdings Inc. (0001980845) (Issuer)
• 342d
  SEC Form 3 filed by new insider Buck Jill

  3 - enGene Holdings Inc. (0001980845) (Issuer)
• 382d
  SEC Form 3 filed by new insider Pott Amy

  3 - enGene Holdings Inc. (0001980845) (Issuer)
• 601d
  SEC Form 3 filed by new insider Connolly Joan

  3 - enGene Holdings Inc. (0001980845) (Issuer)
• 689d
  SEC Form 3 filed by new insider Pruthi Raj Som

  3 - enGene Holdings Inc. (0001980845) (Issuer)
• 691d
  SEC Form 3 filed by new insider Cooper Ronald Harold Wilfred

  3 - enGene Holdings Inc. (0001980845) (Issuer)
• 759d
  SEC Form 3 filed by new insider Hastings Paul J

  3 - enGene Holdings Inc. (0001980845) (Issuer)
• 759d
  SEC Form 3 filed by new insider Joustra Wouter

  3 - enGene Holdings Inc. (0001980845) (Issuer)

Other ENGN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends